We have located links that may give you full text access.
UV-visible absorption spectra of [Ru(E)(E')(CO)(2)(iPr-DAB)] (E = E' = SnPh(3) or Cl; E = SnPh(3) or Cl, E' = CH(3); iPr-DAB = N,N'-Di-isopropyl-1,4-diaza-1,3-butadiene): combination of CASSCF/CASPT2 and TD-DFT calculations.
Journal of the American Chemical Society 2001 November 22
The UV-visible absorption spectra of [Ru(E)(E')(CO)(2)(iPr-DAB)] (E = E' = SnPh(3) or Cl; E = SnPh(3) or Cl, E' = CH(3); iPr-DAB = N,N'-di-isopropyl-1,4-diaza-1,3-butadiene) are investigated using CASSCF/CASPT2 and TD-DFT calculations on model complexes [Ru(E)(E')(CO)(2)(Me-DAB)] (E = E' = SnH(3) or Cl; E = SnH(3) or Cl, E' = CH(3); Me-DAB = N,N'-dimethyl-1,4-diaza-1,3-butadiene). The calculated transition energies and oscillator strengths allow an unambiguous assignment of the spectra of the nonhalide complexes [Ru(SnPh(3))(2)(CO)(2)(iPr-DAB)] and [Ru(SnPh(3))(Me)(CO)(2)(iPr-DAB)]. The agreement between the CASSCF/CASPT2 and TD-DFT approaches is remarkably good in the case of these nonhalide complexes. The lowest-energy part of the spectrum (visible absorption) originates in electronic transitions that correspond to excitations from the axial E-Ru-E' sigma(2) orbital into the low-lying pi(DAB) orbital (sigma-bond-to-ligand charge transfer, SBLCT, transitions), while the absorption between 25 000 and 35 000 cm(-1) is due to metal-to-ligand charge transfer (MLCT) excitations from the 4d(Ru) orbitals to pi(DAB) (MLCT). Above 35 000 cm(-1), the transitions mostly correspond to MLCT and SBLCT excitations into pi(CO) orbitals. Analysis of the occupied sigma orbitals involved in electronic transitions of the nonhalide complexes shows that the Kohn-Sham orbitals are generally more delocalized than their CASSCF/CASPT2 counterparts. The CASSCF/CASPT2 and TD-DFT approaches lead to different descriptions of electronic transitions of the halide complexes [Ru(Cl)(2)(CO)(2)(Me-DAB)] and [Ru(Cl)(Me)(CO)(2)(Me-DAB)]. CASSCF/CASPT2 reproduces well the observed blue-shift of the lowest absorption band on going from the nonhalide to halide complexes. TD-DFT systematically underestimates the transition energies of these complexes, although it reproduces the general spectral features. The CASSCF/CASPT2 and TD-DFT techniques differ significantly in their assessment of the chloride contribution. Thus, CASSCF/CASPT2 assigns the lowest-energy absorption to predominantly Ru --> DAB MLCT transitions, while TD-DFT predicts a mixed XLCT/MLCT character, with the XLCT component being predominant. (XLCT stands for halide (X)-to-ligand-charge transfer.) Analysis of Kohn-Sham orbitals shows a very important 3p(Cl) admixture into the high-lying occupied orbitals, in contrast to the CASSCF/CASSPT2 molecular orbitals which are nearly pure 4d(Ru) with the usual contribution of the back-donation to pi(CO) orbitals. Further dramatic differences were found between characters of the occupied sigma orbitals, as calculated by CASSCF/CASPT2 and DFT. They differ even in their bonding character with respect to the axial E-Ru and Cl-Ru bonds. These differences are attributed to a drawback of the DFT technique with respect to the dynamical correlation effects which become very important in complexes with a polar Ru-Cl bond. Similar differences in the CASSCF/CASPT2 and TD-DFT descriptions of the lowest allowed transition of [Ru(Cl)(2)(CO)(2)(Me-DAB)] and [Ru(Cl)(Me)(CO)(2)(Me-DAB)] were found by comparing the changes of Mulliken population upon excitation. This comparison also reveals that CASSCF/CASPT2 generally predicts smaller electron density redistribution upon excitation than TD-DFT, despite the more localized character of CASSCF/CASPT2 molecular orbitals.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app